Immunomodulation to Prevent or Treat Neonatal Sepsis: Past, Present, and Future

INIS

• therapy 100%
• reviews 100%
• inflammation 100%
• physiology 50%
• mortality 50%
• receptors 50%
• children 50%
• clinical trials 50%
• morbidity 50%
• units 50%
• interventions 50%
• death 50%
• populations 50%
• stem cells 50%
• proteins 50%
• neonates 50%
• breasts 50%
• medicine 50%
• adults 50%
• shape 50%
• peptides 50%
• pattern recognition 50%
• milk 50%
• lactoferrin 50%

Keyphrases

• Immunomodulation 100%
• Neonatal Sepsis 100%
• Futures Past 100%
• Past-present 100%
• Sepsis 75%
• Treatment Options 25%
• Response to Infection 25%
• Clinical Trials 25%
• Neonate 25%
• Older Adults 25%
• Neonatal Intensive Care Unit 25%
• Older children 25%
• Preventive Treatment 25%
• Immune Response 25%
• Age-specific 25%
• Pattern Recognition Receptors 25%
• Clinical Presentation 25%
• Adjuvant Therapy 25%
• Leading Causes of Death 25%
• Perinatal Period 25%
• Antimicrobial Peptides 25%
• Stem Cell Therapy 25%
• Breast Milk 25%
• Acute Inflammatory Response 25%
• Review Strategy 25%
• Pentoxifylline 25%
• Antimicrobial Proteins 25%
• Immune Ontogeny 25%
• Response Strategies 25%
• Inflammatory Immune Response 25%
• Lactoferrin 25%
• Protective Immune Response 25%
• Neonatal Medicine 25%
• Neonatal Immune System 25%

Medicine and Dentistry

• Immunomodulation 100%
• Neonatal Sepsis 100%
• Sepsis 75%
• Immune Response 50%
• Lactoferrin 25%
• Medicine 25%
• Serositis 25%
• Infection 25%
• Adjuvant Therapy 25%
• Clinical Trial 25%
• Antiinfective Agent 25%
• Human Milk 25%
• Pattern Recognition Receptor 25%
• Neonate 25%
• Neonatal Intensive Care Unit 25%
• Perinatal Period 25%
• Pentoxifylline 25%
• Stem Cell Therapy 25%
• Peptides and Proteins 25%
• Ontogeny 25%
• Probiotics 25%
• Immune System 25%